These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 344104)

  • 41. Symptoms from Corynebacterium parvum.
    McIntosh IH; Thynne GS; Bejrajati P; Greening WP
    Lancet; 1976 Oct; 2(7989):803-4. PubMed ID: 61475
    [No Abstract]   [Full Text] [Related]  

  • 42. Corynebacterium parvum toxicity in patients with limited and advanced malignancy.
    Hirshaut Y; Pinsky CM; Wanebo HJ; Braun DW
    Eur J Cancer Clin Oncol; 1984 May; 20(5):583-91. PubMed ID: 6539697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma.
    Gall SA; DiSaia PJ; Schmidt H; Mittelstaedt L; Newman P; Creasman W
    Am J Obstet Gynecol; 1978 Nov; 132(5):555-60. PubMed ID: 717456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personal experience with Corynebacterium parvum in human cancers.
    Israël L; Edelstein R
    World J Surg; 1977 Sep; 1(5):585-95. PubMed ID: 602233
    [No Abstract]   [Full Text] [Related]  

  • 45. Assessment of response to therapy in advanced breast cancer (an amendment).
    Hayward JL; Carbone PP; Rubens RD; Heuson JC; Kumaoka S; Segaloff A
    Br J Cancer; 1978 Jul; 38(1):201. PubMed ID: 687517
    [No Abstract]   [Full Text] [Related]  

  • 46. Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland.
    Hayward JL; Rubens RD; Carbone PP; Heuson JC; Kumaoka S; Segaloff A
    Eur J Cancer (1965); 1978 Nov; 14(11):1291-2. PubMed ID: 738335
    [No Abstract]   [Full Text] [Related]  

  • 47. A trial of nonspecific immunotherapy using systemic C. parvum in treated patients with Dukes B and C colorectal cancer.
    Souter RG; Gill PG; Morris PJ
    Br J Cancer; 1982 Apr; 45(4):506-12. PubMed ID: 7041943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase I study of a multi-modal schedule with Corynebacterium parvum.
    McIntosh IH; Thynne GS; Bejrajati P; Walsh G; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():477-82. PubMed ID: 344102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
    Webster DJ; Chare MJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A survey of patients' reactions to intravenous Corynebacterium parvum therapy.
    Palmer BV; Walsh G; Smedley P; McIntosh IH; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():529-33. PubMed ID: 608547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
    Bast RC; Berek JS; Obrist R; Griffiths CT; Berkowitz RS; Hacker NF; Parker L; Lagasse LD; Knapp RC
    Cancer Res; 1983 Mar; 43(3):1395-401. PubMed ID: 6825108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical studies with Corynebacterium parvum.
    Mitcheson HD; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():509-14. PubMed ID: 344105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience in the use of C. parvum in the treatment of locally advanced carcinoma of the breast.
    Chare MJ; Webster DJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():495-9. PubMed ID: 344104
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.